A high growth, small-cap medical device company was interested in devising an ESG disclosure strategy to enable more effective engagement with investors and other stakeholders.
The company partnered with Gilmartin Group’s ESG team to lead an ESG report development project and educate the management team about the ESG landscape. Leveraging healthcare industry expertise and extensive working knowledge of industry-specific evaluation criteria, Gilmartin Group completed an in-depth assessment of the client’s ESG ratings, peer practices, and investor expectations. This was followed by a systematic prioritization of the company’s most relevant ESG issues, development of action plans to address perceived performance gaps, and consultation meetings with functional leads and subject-matter experts from across the company to gather key internal information and data. Gilmartin Group’s ESG disclosure templates are aligned with recognized ESG standards, including the Sustainability Accounting Standards Board (SASB) standards, as part of a proprietary framework designed to facilitate comprehensive and efficient ESG disclosure development.
The client’s inaugural ESG report was well received by the investment community and captured all elements of the client’s ESG policies, practices, data, and focus areas in a single document, providing a strong foundation for ESG engagement. Beyond the ESG reporting project, Gilmartin’s ESG team helped the client identify forward-looking ESG goals and initiatives to create a multi-year ESG roadmap.
Our clients are leaders and innovators across the MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostic sectors
Gilmartin has a number of resources, from blog posts to webinars designed to educate and help your company achieve success.